{"id":"https://openalex.org/W7223669966","doi":"https://doi.org/10.1111/bjh.70917","title":"Brentuximab vedotin\u2010containing regimen time toxicity for front\u2010line therapy of advanced\u2010stage classical Hodgkin lymphoma in young adults and adults: Real\u2010life comparison between condensed BrECADD versus traditional Bv + AVD","display_name":"Brentuximab vedotin\u2010containing regimen time toxicity for front\u2010line therapy of advanced\u2010stage classical Hodgkin lymphoma in young adults and adults: Real\u2010life comparison between condensed BrECADD versus traditional Bv + AVD","publication_year":2026,"publication_date":"2026-10-26","ids":{"openalex":"https://openalex.org/W7223669966","doi":"https://doi.org/10.1111/bjh.70917","pmid":"https://pubmed.ncbi.nlm.nih.gov/42934121"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.70917","doi":"https://doi.org/10.1111/bjh.70917","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.70917","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70917","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70917","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059488532","display_name":"Marco Picardi","orcid":"https://orcid.org/0000-0001-8508-2524","observed_orcids":["https://orcid.org/0000-0001-8508-2524"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Picardi","raw_affiliation_strings":["Department of Clinical Medicine and Surgery, Hematology Unit Federico II University Medical School  Naples Italy"],"raw_orcid":"https://orcid.org/0000-0001-8508-2524","affiliations":[{"raw_affiliation_string":"Department of Clinical Medicine and Surgery, Hematology Unit Federico II University Medical School  Naples Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003718202","display_name":"Annamaria Vincenzi","orcid":"https://orcid.org/0009-0003-5975-9388","observed_orcids":["https://orcid.org/0009-0003-5975-9388"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Annamaria Vincenzi","raw_affiliation_strings":["Department of Clinical Medicine and Surgery, Hematology Unit Federico II University Medical School  Naples Italy"],"raw_orcid":"https://orcid.org/0009-0003-5975-9388","affiliations":[{"raw_affiliation_string":"Department of Clinical Medicine and Surgery, Hematology Unit Federico II University Medical School  Naples Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057084037","display_name":"Fabrizio Pane","orcid":"https://orcid.org/0000-0003-2563-4125","observed_orcids":["https://orcid.org/0000-0003-2563-4125"]},"institutions":[{"id":"https://openalex.org/I4210117450","display_name":"Federico II University Hospital","ror":"https://ror.org/02jr6tp70","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]},{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fabrizio Pane","raw_affiliation_strings":["Department of Clinical Medicine and Surgery, Hematology Unit Federico II University Medical School  Naples Italy"],"raw_orcid":"https://orcid.org/0000-0003-2563-4125","affiliations":[{"raw_affiliation_string":"Department of Clinical Medicine and Surgery, Hematology Unit Federico II University Medical School  Naples Italy","institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5003718202"],"corresponding_institution_ids":["https://openalex.org/I4210117450","https://openalex.org/I71267560"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":4.0174,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.95197582,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brentuximab-vedotin","display_name":"brentuximab vedotin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5730000138282776},{"id":"https://openalex.org/keywords/real-world-comparison","display_name":"real-world comparison","score":0.7369999885559082},{"id":"https://openalex.org/keywords/young-adults","display_name":"young adults","score":0.7889999747276306},{"id":"https://openalex.org/keywords/adults","display_name":"adults","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C2910914307","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Classical Hodgkin lymphoma","level":4,"score":0.9199000000953674},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8464999794960022},{"id":"https://openalex.org/C2778191690","wikidata":"https://www.wikidata.org/wiki/Q422324","display_name":"Brentuximab vedotin","level":4,"score":0.8230000138282776},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.7860000133514404},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.7001000046730042},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6187999844551086},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6011999845504761},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5475000143051147},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.42660000920295715},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4101000130176544},{"id":"https://openalex.org/C2908731994","wikidata":"https://www.wikidata.org/wiki/Q2509220","display_name":"Hematologic Neoplasms","level":3,"score":0.3160000145435333},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.30169999599456787},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.30079999566078186},{"id":"https://openalex.org/C2779390272","wikidata":"https://www.wikidata.org/wiki/Q2167074","display_name":"Reed\u2013Sternberg cell","level":4,"score":0.2849999964237213},{"id":"https://openalex.org/C2779020855","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin's lymphoma","level":3,"score":0.27399998903274536},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.26440000534057617},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.2605000138282776},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.25769999623298645},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.25600001215934753}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1111/bjh.70917","doi":"https://doi.org/10.1111/bjh.70917","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.70917","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70917","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:42934121","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42934121","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Letter"}],"best_oa_location":{"id":"doi:10.1111/bjh.70917","doi":"https://doi.org/10.1111/bjh.70917","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.70917","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.70917","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223669966.pdf","grobid_xml":"https://content.openalex.org/works/W7223669966.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W2489390482","https://openalex.org/W4214862515","https://openalex.org/W4400268343","https://openalex.org/W4415979921","https://openalex.org/W7168285447","https://openalex.org/W7203934677"],"related_works":["https://openalex.org/W7203934677","https://openalex.org/W3194116711","https://openalex.org/W7168285447","https://openalex.org/W4294300762","https://openalex.org/W4386022324","https://openalex.org/W2981162599","https://openalex.org/W3029062084","https://openalex.org/W4415396881","https://openalex.org/W4402518760","https://openalex.org/W3086825036"],"abstract_inverted_index":{"We":[0],"read":[1],"with":[2,114,166,281,356,382,424],"great":[3],"enthusiasm":[4],"the":[5,21,60,70,76,91,103,107,140,159,167,171,328,335,351,446,495,549,559],"report":[6,77],"by":[7,78,242],"Jaworek":[8,79,199],"et":[9,80,200,303],"al.":[10,201],"published":[11],"in":[12,17,39,307,315,323,393,410,436,500],"British":[13],"Journal":[14],"of":[15,23,31,110,117,134,173,205,210,274,288,309,376,387,396,502,551],"Haematology":[16],"August":[18],"2026":[19],"describing":[20],"implementation":[22],"a":[24,63,115],"condensed":[25,104,464],"3-day":[26,105,465],"BrECADD":[27,73,88,240,272,453,469],"for":[28,252,320,505],"front-line":[29,343,369,498],"treatment":[30,48,262,295,330],"advanced-stage":[32],"(AS)":[33],"classical":[34],"Hodgkin":[35],"lymphoma":[36],"(cHL)":[37],"mostly":[38],"young":[40],"adults":[41,43],"and":[42,66,148,155,162,176,221,232,317,412,431,470,484,513,526,542],"(YA&A).1":[44],"By":[45],"reducing":[46,152,238,327],"intravenous":[47],"from":[49,198,267,558],"4":[50,488],"to":[51,69,98,192,260,297,334,342,445,569],"3":[52,299],"days":[53,109,138],"per":[54],"cycle":[55,241],"while":[56,151],"preserving":[57],"dose":[58],"intensity,":[59],"authors":[61,126],"offer":[62],"more":[64],"convenient":[65],"resource-efficient":[67],"alternative":[68],"original":[71,141,467,517,530],"HD21":[72],"schedule.2":[74],"In":[75,284,371,456],"al.,1":[81],"24":[82],"patients":[83,93,161,211,276,289,378],"(80%)":[84],"required":[85,212,414],"only":[86,291],"four":[87,228,292],"cycles,":[89,293],"whereas":[90],"remaining":[92],"received":[94,290],"six":[95,385],"cycles":[96,206,386],"according":[97],"interim":[99],"PET":[100],"results.":[101],"With":[102],"BrECADD,":[106,466],"overage":[108],"infusions":[111],"were":[112,207],"13.2":[113],"range":[116],"12\u201318":[118],"days.":[119,399],"The":[120,125,400,545,562],"1-year":[121],"PFS":[122,402],"was":[123,130,403],"100%.":[124],"underlined":[127],"that":[128,462,547],"there":[129,476],"about":[131],"25%":[132],"reduction":[133],"cytotoxic":[135],"agent":[136],"infusion":[137,398],"versus":[139,451],"BrECADD.1,":[142],"2":[143],"This":[144,360],"may":[145,256,347,442],"improve":[146],"convenience":[147],"healthcare":[149,168,248,353,449],"efficiency":[150],"hospital":[153],"visits":[154],"\u2018time":[156],"toxicity\u2019,":[157],"namely":[158],"time":[160,182,354,482],"caregivers":[163],"spend":[164],"interacting":[165],"system":[169],"at":[170],"expense":[172],"personal,":[174],"professional":[175],"social":[177],"life.3":[178],"While":[179],"focusing":[180],"on":[181,494,556],"toxicity":[183,483],"is":[184,362,477],"crucial,":[185],"its":[186],"evaluation":[187],"should":[188],"not":[189,348,565],"be":[190],"limited":[191],"scheduled":[193],"chemotherapy":[194],"visits.4":[195],"Three":[196],"points":[197],"deserve":[202,491],"attention:":[203],"33%":[204],"inpatient,":[208],"37%":[209],"unplanned":[213,250,415],"hospitalization":[214,306,416],"(median":[215,277,417],"6":[216,337],"days;":[217],"range,":[218],"1\u201316":[219],"days)":[220],"20%":[222],"developed":[223],"grade":[224,311],"\u22653":[225,312,406],"infections,":[226],"including":[227,427],"respiratory":[229],"viral":[230],"infections":[231,322],"two":[233],"bacterial":[234],"bloodstream":[235],"infections.":[236],"Although":[237],"each":[239],"one":[243],"administration":[244],"day":[245],"decreases":[246],"planned":[247,329],"contacts,":[249],"hospitalizations":[251],"severe":[253,321],"treatment-related":[254],"complications":[255],"still":[257],"substantially":[258],"contribute":[259],"overall":[261],"burden.":[263],"Similar":[264],"findings":[265,550],"emerged":[266],"another":[268],"recent":[269],"multicentre":[270,373],"real-world":[271,374,452],"study":[273,553],"100":[275],"age,":[278],"30":[279],"years)":[280],"AS":[282,345,383,503],"cHL.5":[283],"this":[285,552],"cohort,":[286],"83%":[287],"limiting":[294],"duration":[296],"approximately":[298],"months.":[300],"However,":[301],"Porges":[302],"al.5":[304],"reported":[305],"65%":[308],"patients,":[310],"febrile":[313,407],"neutropenia":[314,408],"55%":[316],"intensive-care":[318],"admission":[319],"5%.":[324],"Thus,":[325],"significantly":[326],"period":[331],"(as":[332],"compared":[333],"typical":[336],"months":[338],"used":[339,435],"until":[340],"now":[341],"treat":[344],"cHL)":[346],"necessarily":[349],"capture":[350],"entire":[352],"associated":[355],"an":[357,394,478],"intensive":[358],"regimen.":[359],"perspective":[361],"pertinent":[363],"when":[364],"considering":[365],"other":[366],"contemporary":[367],"Bv-based":[368],"strategies.":[370],"our":[372,437],"series":[375,454],"150":[377],"aged":[379],"18\u201359":[380],"years":[381],"cHL,6":[384],"1-day":[388,472],"Bv":[389,473],"+":[390,474],"AVD":[391],"resulted":[392],"average":[395],"12":[397],"2-year":[401],"91%.":[404],"Grade":[405],"occurred":[409],"3%,":[411],"10%":[413],"stay,":[418],"1.5":[419],"days).":[420],"Structured":[421],"supportive":[422],"care":[423],"primary":[425],"prophylaxis":[426],"long-acting":[428],"glyco-pegylated":[429],"G-CSF":[430],"antimicrobial":[432],"drugs,":[433],"routinely":[434],"clinical":[438],"practice":[439],"(Figure":[440],"1),":[441],"have":[443],"contributed":[444],"lower":[447],"acute":[448],"utilization":[450],"utilizations.":[455],"conclusion,":[457],"among":[458],"brentuximab":[459],"vedotin-containing":[460],"regimens,":[461],"is,":[463],"4-day":[468],"traditional":[471],"AVD,":[475],"important":[479],"variability":[480],"regarding":[481],"likely":[485],"financial":[486],"toxicity.3,":[487],"These":[489],"features":[490],"some":[492],"thought":[493],"most":[496],"cost-effective":[497],"treatment,":[499],"real-life,":[501],"cHL":[504],"YA&A.":[506],"Marco":[507],"Picardi:":[508],"Conceptualization;":[509],"writing":[510,515,523,528],"\u2013":[511,516,524,529,540],"review":[512,525,541],"editing;":[514,527,543],"draft;":[518,531],"supervision.":[519,544],"Annamaria":[520],"Vincenzi:":[521],"Methodology;":[522],"validation;":[532],"visualization;":[533],"data":[534,546,563],"curation;":[535],"investigation.":[536],"Fabrizio":[537],"Pane:":[538],"Writing":[539],"support":[548],"are":[554,564],"available":[555,567],"request":[557],"corresponding":[560],"author.":[561],"publicly":[566],"due":[568],"privacy":[570],"or":[571],"ethical":[572],"restrictions.":[573]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-27T00:00:00"}